^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

EGFR S492R

i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Entrez ID:
Phase 2
M.D. Anderson Cancer Center
Active, not recruiting
Last update posted :
12/21/2023
Initiation :
12/29/2017
Primary completion :
01/31/2025
Completion :
01/31/2025
KRAS • BRAF • NRAS • MAP2K1
|
KRAS mutation • BRAF mutation • NRAS mutation • KRAS wild-type • RAS wild-type • NRAS wild-type • KRAS exon 2 mutation • EGFR S492R • KRAS exon 2 wild-type
|
Mekinist (trametinib) • Vectibix (panitumumab)